• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗氧化剂补充剂与绝经后女性乳腺癌复发风险及乳腺癌相关死亡率

Antioxidant supplements and risk of breast cancer recurrence and breast cancer-related mortality among postmenopausal women.

作者信息

Fleischauer Aaron T, Simonsen Neal, Arab Lenore

机构信息

Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599, USA.

出版信息

Nutr Cancer. 2003;46(1):15-22. doi: 10.1207/S15327914NC4601_02.

DOI:10.1207/S15327914NC4601_02
PMID:12925299
Abstract

Despite widespread use, only a few clinical or epidemiological studies have examined the relationship between antioxidant supplements and risk of breast cancer recurrence or breast cancer-related mortality. We used proportional hazards and logistic regression modeling to estimate rate ratios and odds ratios (ORs) for recurrence and mortality among 385 postmenopausal women diagnosed with breast cancer between 1986 and 1988 enrolled into a case-control study on diet and cancer. Women were recontacted with a single questionnaire to ascertain the use of nutritional supplements during 12-14 yr of follow-up time. In multivariable models, antioxidant supplement users compared with nonusers were less likely to have a breast cancer recurrence or breast cancer-related death (OR = 0.54, 95% CI = 0.27-1.04). Vitamin E supplements showed a modest protective effect when used for more than 3 yr (OR = 0.33, 95% CI = 0.10-1.07). Premorbid dietary intake of vitamins C or E from diet, supplements, or both showed no relationship with risk. Risks of recurrence and disease-related mortality were reduced among women using vitamin C and vitamin E supplements for more than 3 yr. Recall bias among proxy respondents for women who died during follow-up may have contributed to these findings. This study provides limited support for the hypothesis that antioxidant supplements may reduce the risk of breast cancer recurrence or breast cancer-related mortality.

摘要

尽管抗氧化剂补充剂被广泛使用,但仅有少数临床或流行病学研究探讨了其与乳腺癌复发风险或乳腺癌相关死亡率之间的关系。我们使用比例风险模型和逻辑回归模型,对1986年至1988年间确诊为乳腺癌的385名绝经后女性进行病例对照研究,以估计复发率和死亡率的比率及比值比(OR)。这些女性参与了一项关于饮食与癌症的病例对照研究。我们通过一份单一问卷再次联系这些女性,以确定她们在12至14年随访期间营养补充剂的使用情况。在多变量模型中,与未使用抗氧化剂补充剂的女性相比,使用抗氧化剂补充剂的女性乳腺癌复发或乳腺癌相关死亡的可能性较小(OR = 0.54,95%置信区间 = 0.27 - 1.04)。维生素E补充剂使用超过3年时显示出适度的保护作用(OR = 0.33,95%置信区间 = 0.10 - 1.07)。病前从饮食、补充剂或两者中摄入的维生素C或E与风险无关。使用维生素C和维生素E补充剂超过3年的女性复发风险和疾病相关死亡率降低。随访期间死亡女性的代理受访者存在的回忆偏倚可能导致了这些结果。本研究为抗氧化剂补充剂可能降低乳腺癌复发风险或乳腺癌相关死亡率这一假设提供了有限的支持。

相似文献

1
Antioxidant supplements and risk of breast cancer recurrence and breast cancer-related mortality among postmenopausal women.抗氧化剂补充剂与绝经后女性乳腺癌复发风险及乳腺癌相关死亡率
Nutr Cancer. 2003;46(1):15-22. doi: 10.1207/S15327914NC4601_02.
2
Dietary antioxidants, supplements, and risk of epithelial ovarian cancer.膳食抗氧化剂、补充剂与上皮性卵巢癌风险
Nutr Cancer. 2001;40(2):92-8. doi: 10.1207/S15327914NC402_3.
3
Dietary fat, fiber, vegetable, and micronutrients are associated with overall survival in postmenopausal women diagnosed with breast cancer.膳食脂肪、纤维、蔬菜和微量营养素与被诊断患有乳腺癌的绝经后女性的总生存率相关。
Nutr Cancer. 2006;55(2):132-40. doi: 10.1207/s15327914nc5502_3.
4
Nutrient intakes from foods and dietary supplements in women at risk for breast cancer recurrence. The Women's Healthy Eating and Living Study Group.乳腺癌复发风险女性通过食物和膳食补充剂的营养摄入量。女性健康饮食与生活研究小组。
Nutr Cancer. 1997;29(2):133-9. doi: 10.1080/01635589709514614.
5
Vitamin C and vitamin E supplement use and colorectal cancer mortality in a large American Cancer Society cohort.美国癌症协会一项大型队列研究中维生素C和维生素E补充剂的使用与结直肠癌死亡率
Cancer Epidemiol Biomarkers Prev. 2001 Jan;10(1):17-23.
6
Dairy, calcium, and vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II Nutrition Cohort.癌症预防研究II营养队列中的乳制品、钙和维生素D摄入量与绝经后乳腺癌风险
Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2898-904. doi: 10.1158/1055-9965.EPI-05-0611.
7
Breast cancer and dietary factors in Taiwanese women.台湾女性的乳腺癌与饮食因素
Cancer Causes Control. 2005 Oct;16(8):929-37. doi: 10.1007/s10552-005-4932-9.
8
Dietary carotenoids and risk of hormone receptor-defined breast cancer in a prospective cohort of Swedish women.饮食类胡萝卜素与瑞典女性前瞻性队列中激素受体定义的乳腺癌风险
Eur J Cancer. 2010 Apr;46(6):1079-85. doi: 10.1016/j.ejca.2010.01.004. Epub 2010 Jan 28.
9
Intakes of vitamin A, C, and E, and beta-carotene are associated with risk of cervical cancer: a case-control study in Korea.摄入维生素 A、C、E 和β-胡萝卜素与宫颈癌风险相关:韩国的一项病例对照研究。
Nutr Cancer. 2010;62(2):181-9. doi: 10.1080/01635580903305326.
10
Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women.绝经后女性膳食抗氧化维生素与冠心病死亡
N Engl J Med. 1996 May 2;334(18):1156-62. doi: 10.1056/NEJM199605023341803.

引用本文的文献

1
Microalgae: A Treasure Trove of Anticancer Nutraceuticals and Promising Therapeutic Mechanisms.微藻:抗癌营养保健品的宝库及有前景的治疗机制
Adv Biomed Res. 2025 Jan 30;14:5. doi: 10.4103/abr.abr_101_24. eCollection 2025.
2
Antioxidant and Antiproliferative Activities of (L.) L. Extract and Isolated Compounds.(L.)L.提取物及其分离化合物的抗氧化和抗增殖活性。
Molecules. 2023 Oct 30;28(21):7354. doi: 10.3390/molecules28217354.
3
Postdiagnosis dietary factors, supplement use and breast cancer prognosis: Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis.
诊断后饮食因素、补充剂使用与乳腺癌预后:全球癌症更新计划(CUP Global)系统文献回顾和荟萃分析。
Int J Cancer. 2023 Feb 15;152(4):616-634. doi: 10.1002/ijc.34321. Epub 2022 Oct 24.
4
Serine O-acetyltransferase derived NV14 peptide reduces cytotoxicity in HO induced MDCK cells and inhibits MCF-7 cell proliferation through caspase gene expression.丝氨酸 O-乙酰转移酶衍生的 NV14 肽可减少 HO 诱导的 MDCK 细胞的细胞毒性,并通过半胱天冬酶基因表达抑制 MCF-7 细胞的增殖。
Mol Biol Rep. 2022 Oct;49(10):9205-9215. doi: 10.1007/s11033-022-07746-x. Epub 2022 Aug 8.
5
Dihydropyrazole-Carbohydrazide Derivatives with Dual Activity as Antioxidant and Anti-Proliferative Drugs on Breast Cancer Targeting the HDAC6.具有双重活性的二氢吡唑-碳酰肼衍生物作为针对HDAC6的乳腺癌抗氧化和抗增殖药物
Pharmaceuticals (Basel). 2022 May 31;15(6):690. doi: 10.3390/ph15060690.
6
Dietary Factors and Breast Cancer Prognosis among Breast Cancer Survivors: A Systematic Review and Meta-Analysis of Cohort Studies.乳腺癌幸存者的饮食因素与乳腺癌预后:队列研究的系统评价和荟萃分析
Cancers (Basel). 2021 Oct 23;13(21):5329. doi: 10.3390/cancers13215329.
7
BRCA1 Promoter Methylation and Clinicopathological Characteristics in Sporadic Breast Cancer Patients in Indonesia.印度尼西亚散发性乳腺癌患者中BRCA1启动子甲基化与临床病理特征
Asian Pac J Cancer Prev. 2018 Sep 26;19(9):2643-2649. doi: 10.22034/APJCP.2018.19.9.2643.
8
The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.作为乳腺癌免疫治疗靶点的先天性和适应性浸润免疫系统。
Endocr Relat Cancer. 2017 Apr;24(4):R123-R144. doi: 10.1530/ERC-16-0404. Epub 2017 Feb 13.
9
Adherence to Guidelines for Cancer Survivors and Health-Related Quality of Life among Korean Breast Cancer Survivors.韩国乳腺癌幸存者对癌症幸存者指南的遵循情况及与健康相关的生活质量
Nutrients. 2015 Dec 9;7(12):10307-19. doi: 10.3390/nu7125532.
10
Cytotoxic effects of Mangifera indica L. kernel extract on human breast cancer (MCF-7 and MDA-MB-231 cell lines) and bioactive constituents in the crude extract.番木瓜核提取物对人乳腺癌(MCF-7 和 MDA-MB-231 细胞系)的细胞毒性作用及粗提取物中的生物活性成分。
BMC Complement Altern Med. 2014 Jun 25;14:199. doi: 10.1186/1472-6882-14-199.